Requires manufacturer of recalled medical devices to provide replacement device or pay for replacement device under certain circumstances.
Impact
The introduction of A1399 signifies a substantial shift in how the state of New Jersey regulates the responsibilities of medical device manufacturers during recalls. By enforcing a clear obligation on manufacturers to either replace or reimburse for recalled products, the state aims to bolster consumer confidence in medical devices. The bill aligns with existing consumer protection laws, facilitating a more robust framework for addressing the risks associated with defective medical products. It also empowers consumers to hold manufacturers accountable for their products.
Summary
Assembly Bill A1399 requires manufacturers of recalled medical devices to provide consumers with a replacement device or to cover the cost of a replacement device under specified conditions. This legislation aims to enhance consumer safety by ensuring that individuals who are impacted by the recall of medical devices receive timely replacements or compensations. The bill mandates that manufacturers comply with these provisions within 30 days of a recall being issued, which emphasizes the urgency of consumer safety in the medical field.
Contention
Notably, the bill establishes that failing to comply with these requirements constitutes an unlawful practice under the New Jersey Consumer Fraud Act, subjecting manufacturers to significant penalties. Each violation could result in a fine of up to $10,000 for the first infraction and $20,000 for subsequent violations, alongside potential punitive damages and the possibility of cease and desist orders by the Attorney General. Such stringent measures have sparked discussions regarding manufacturers' responsibilities and the balance between corporate liability and consumer protection.
An Act to Require the Cooperation of Original Manufacturers of Electronic Devices to Facilitate the Repair of Those Devices by Device Owners and Independent Repair Providers
Relative to tenant and contract manufacturers of beer, wine, and liquor; allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court; and, restricting the purchase of real property on or around military installations.